In summary, our mouse genetic studies have revealed the importance of the BH3-only proteins Puma and Noxa for the efficacy of cytotoxic drugs currently used to treat MLL-AF9 AML. The gene discussed is KMT2A; the disease is acute myeloid leukemia.